UCHL5 and neoplasm: The results demonstrated that UCHL5 expression was upregulated in 64 (87.7%), unchanged in 6 (8.2%) and downregulated in 3 (4.1%) tumor tissues in comparison with the paired non-cancerous tissues out of 73 patients (p<0.0001, chi-squared test; Figure 2B).